DOI: 10.1055/s-00023610

Drug Research

LinksClose Window

References

Bagca BG, Avci CB.
Overview of the COVID-19 and JAK/STAT Pathway Inhibition: Ruxolitinib Perspective.

Cytokine & Growth Factor Reviews 2020;
54: 51-61

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.